📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model. (2018)

First Author: Hamilton P

Attributed to: Understanding the autoimmune mechanism in idiopathic membranous nephropathy (IMN) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ndt/gfy049

PubMed Identifier: 29617884

Publication URI: http://europepmc.org/abstract/MED/29617884

Type: Journal Article/Review

Volume: 33

Parent Publication: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Issue: 12

ISSN: 0931-0509